2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Nutrient deprivation, specifically targeting glucose metabolism, is a viable strategy for inhibiting cancer cell proliferation and survival.
• 2-deoxy-d-glucose (2-DG) acts as a glucose analog, interfering with cellular energy pathways.

Purpose of the Study:

• To review the molecular mechanisms by which 2-DG affects cancer cells.
• To discuss the therapeutic potential and ongoing research of 2-DG and its analogs in cancer treatment.

Main Methods:

• The review synthesizes existing research on 2-DG's effects on glucose metabolism.
• It examines the biochemical pathways impacted by 2-DG, including glycolysis.
• Literature analysis of 2-DG's role as an adjuvant and development of novel analogs.

Main Results:

• 2-DG inhibits glycolysis by forming 2-deoxy-d-glucose-6-phosphate (2-DG6P), which inhibits key enzymes like hexokinase and glucose-6-phosphate isomerase.
• This disruption leads to energy deprivation and subsequent cancer cell death.
• 2-DG impacts multiple molecular processes beyond glycolysis.

Conclusions:

• 2-DG is a potent inhibitor of cancer cell metabolism and survival.
• Further research into 2-DG analogs and its use as an adjuvant therapy holds promise for novel anticancer strategies.